Identifying and using a credible network meta-analysis in allergy, asthma, and immunology: a clinician's guide.
Where this comes from
- Record sourced from PubMed, PMID 42637004.
- Also identified by DOI 10.1016/j.jaip.2026.08.020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Network meta-analyses (NMA) are an increasingly popular method in allergy, asthma, and immunology to inform comparative effectiveness among competing treatment options. They enable comparisons among treatments when no direct comparisons (i.e., head-to-head randomized control trials) exist and strengthen inferences among direct comparisons by incorporating data from indirect comparisons. To inform optimal decision-making, allergy, asthma, and immunology clinicians, peer-reviewers, journal editors, and policymakers must understand the fundamentals of how to assess NMA credibility. Through worked examples supporting AAAAI/ACAAI Task Force on Practice Parameters guidelines, we summarize the process of conducting an NMA and how to interpret results to inform clinical decision-making.